tiprankstipranks
NeuroThera Labs Inc. (TSE:NTLX)
:NTLX
Canadian Market
NTLX
NeuroThera Labs Inc.
RESEARCH TOOLSreports

NeuroThera Labs Inc. (NTLX) Price & Analysis

― Followers

NTLX Stock Chart & Stats

C$0.34
C$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeC$0.10 - C$0.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.90K
Market Cap
C$7.19M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,848,000
10 Day Avg. Volume2,000
30 Day Avg. Volume2,900
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

NeuroThera Labs Inc. News

NeuroThera and Clearmind Secure U.S. Patent Milestone for MDMA-PEA PTSD Therapy
NeuroThera and Clearmind Secure U.S. Patent Milestone for MDMA-PEA PTSD Therapy
The latest announcement is out from NeuroThera Labs Inc. ( ($TSE:NTLX) ). NeuroThera Labs Inc. and Clearmind Medicine...
13h ago
NeuroThera Labs Raises C$2.7 Million in Final Tranche of Private Placement
NeuroThera Labs Raises C$2.7 Million in Final Tranche of Private Placement
An update from NeuroThera Labs Inc. ( ($TSE:NTLX) ) is now available. NeuroThera Labs Inc. has closed the...
7d ago
NeuroThera Labs Raises C$2.7 Million in First Tranche of Private Placement
NeuroThera Labs Raises C$2.7 Million in First Tranche of Private Placement
NeuroThera Labs Inc. ( ($TSE:NTLX) ) has provided an update. NeuroThera Labs Inc. has closed the first tranche...
12d ago
NeuroThera Labs Wins Japanese Patent for Next-Generation Pain and Fever Therapy
NeuroThera Labs Wins Japanese Patent for Next-Generation Pain and Fever Therapy
NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an update. NeuroThera Labs Inc., a clinical-stage biotech and majority-owned...
13d ago
NeuroThera Labs Expands Tourette Drug Trial to Yale in Phase IIb Study
NeuroThera Labs Expands Tourette Drug Trial to Yale in Phase IIb Study
NeuroThera Labs Inc. ( ($TSE:NTLX) ) just unveiled an update. NeuroThera Labs Inc. is a clinical-stage pharmaceutical company...
20d ago
CI Global Asset Management Lowers Risk Ratings on Three Funds, Lifts One
CI Global Asset Management Lowers Risk Ratings on Three Funds, Lifts One
An update from NeuroThera Labs Inc. ( ($TSE:NTLX) ) is now available. CI Global Asset Management has revised...
1M ago
NeuroThera, Clearmind Advance Non-Hallucinogenic Depression Therapy With New Patent Filing
NeuroThera, Clearmind Advance Non-Hallucinogenic Depression Therapy With New Patent Filing
The latest update is out from NeuroThera Labs Inc. ( ($TSE:NTLX) ). NeuroThera Labs Inc. has announced that...
5M ago
NeuroThera and Clearmind Advance Patent for Obesity and Liver Disease Therapy
NeuroThera and Clearmind Advance Patent for Obesity and Liver Disease Therapy
An announcement from NeuroThera Labs Inc. ( ($TSE:NTLX) ) is now available. NeuroThera Labs has advanced its collaboration...
6M ago
NeuroThera Labs to Acquire Majority Stake in Quantum Clinical Trials Firm CliniQuantum
NeuroThera Labs to Acquire Majority Stake in Quantum Clinical Trials Firm CliniQuantum
NeuroThera Labs Inc. ( ($TSE:NTLX) ) has shared an update. NeuroThera Labs Inc. has signed a definitive agreement...
6M ago
Neurothera Labs Wins U.S. Patent for Cannabinoid-Antibiotic Platform Targeting MRSA
Neurothera Labs Wins U.S. Patent for Cannabinoid-Antibiotic Platform Targeting MRSA
NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an announcement. Neurothera Labs has secured a new U.S. patent...
7M ago

NTLX FAQ

What was NeuroThera Labs Inc.’s price range in the past 12 months?
NeuroThera Labs Inc. lowest stock price was C$0.10 and its highest was C$0.40 in the past 12 months.
    What is NeuroThera Labs Inc.’s market cap?
    NeuroThera Labs Inc.’s market cap is C$7.19M.
      When is NeuroThera Labs Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were NeuroThera Labs Inc.’s earnings last quarter?
      Currently, no data Available
      Is NeuroThera Labs Inc. overvalued?
      According to Wall Street analysts NeuroThera Labs Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does NeuroThera Labs Inc. pay dividends?
        NeuroThera Labs Inc. does not currently pay dividends.
        What is NeuroThera Labs Inc.’s EPS estimate?
        NeuroThera Labs Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does NeuroThera Labs Inc. have?
        NeuroThera Labs Inc. has 20,848,000 shares outstanding.
          What happened to NeuroThera Labs Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of NeuroThera Labs Inc.?
          Currently, no hedge funds are holding shares in TSE:NTLX
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            NeuroThera Labs Inc. (NTLX) Earnings & Revenues

            Historic Earnings Reports
            Similar Stocks
            Company
            Price & Change
            Follow
            ―
            ―
            ―
            ―
            ―
            ―
            MYND
            MYND Life Sciences
            ―
            ―
            MBIO
            Mindbio Therapeutics Corp.
            ―
            ―
            NURL
            Neural Therapeutics Inc.
            ―
            ―
            Compare TSE:NTLX Stocks >
            Popular Stocks